Beijing, China

Wenxin Sun

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenxin Sun. Retrieved from https://idiyas.com/inventor/wenxin-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Wenxin Sun

Introduction

Wenxin Sun is a notable inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in vaccine development. His work focuses on innovative approaches to enhance immune responses through recombinant technology.

Latest Patents

Wenxin Sun holds 1 patent for his invention titled "Recombinant chemokine-antigen vaccine." This patent describes a recombinant gene sequence that comprises the human SLC gene, an antigen gene, and an IgG1-Fc fragment gene. The SLC gene is linked upstream to the antigen gene, while the IgG1-Fc fragment is linked downstream to the antigen gene. This invention also relates to the application of the recombinant gene sequence in the preparation of gene vaccines.

Career Highlights

Wenxin Sun is affiliated with the Chinese Academy of Medical Sciences, where he conducts research and develops innovative medical solutions. His work has the potential to significantly impact vaccine efficacy and patient outcomes.

Collaborations

Wenxin collaborates with esteemed colleagues, including Shuren Zhang and Xueyan Zhang, who contribute to his research endeavors.

Conclusion

Wenxin Sun's innovative work in recombinant vaccine technology exemplifies the advancements being made in medical science. His contributions are paving the way for future developments in immunology and vaccine research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…